Vision and Mission
Board of Directors
Member Owned Cooperative
100% Rebate Return
WHAT WE OFFER
GOVT. RELATIONS & NEWS
IPC Legislative Action Center
State Legislative Tracking
Log in to order
Forgot Login Info?
IPC Member Benefits
Rx Generics Huge Savings
Rx Brand Great Pricing
Access to 40+ Vendor Programs
OTC Profit Makers
Govt. Relations - National Updates
Read All National Updates >
Rep. Doug Collins (R-Ga.) Responds to CVS Regarding PBM Issue
Jun 28, 2018
PC encourages all members to contact Rep. Doug Collins (R-GA) and thank him for his recent efforts to stand up for independent pharmacies nationwide. He recently submitted an inspiring letter to the editor which was published in the Wall Street Journal. Please contact the Congressman’s Office and convey your appreciation for his support of independent pharmacy: His office number is 202-225-9893 in Washington.
Medicare Program; Contract Year 2019 Policy and Technical Changes Final Rule
Apr 23, 2018
CMS decided to “kick the can down the road” on DIR fees at this time, but noted that the President’s Fiscal Year 2019 Budget included language that all price concessions should be at the point-of-sale. CMS believes the statute provides them with discretion to require that Part D sponsors apply at least a portion of the manufacturer rebates and all pharmacy price concessions they receive to the price of a Part D drug at the point of sale. Any new requirements regarding the application of rebates at the point of sale will be proposed through notice and comment in future rulemaking.
Reminder - CMS Proposed DIR Rule Comments Due January 16
Jan 12, 2018
As a reminder to all IPC stores, you have until the close of business Tuesday, January 16, 2018 to submit your comments to The Centers for Medicare & Medicaid Services (CMS) supporting its proposed rule that ends the retroactive DIR fees by requiring the PBMs to apply all pharmacy price concessions, including DIR fees, to the price of the drug at the point of sale.
Govt. Relations - State Updates
Read All State Updates >
IPC Ohio Members: Urge Senate to Support HB 479
Jun 29, 2018
Anti-Prescription Clawback Fees and Pharmacy "Gag Orders" PBM Regulation Bill Passed the Ohio House of Representatives Unanimously! Next step is the Senate! HB 479 is now moving to the Senate for action. PBMs and insurers are working to water down the bill over in the Senate, so your activism in the next chapter is even more important than before. Please take the time to contact your Senator and urge them to support the bill's passage.
IPC Ohio Members: Urge House Members to Support HB 479
Jun 26, 2018
Gag Order/Clawback Bill Expected For Vote in Ohio House TOMORROW . Keep Up the Momentum For Passage of Anti-Prescription Clawback Fees & Pharmacy "Gag Orders" PBM Regulation Bill. Issue: Clawback is a tool Pharmacy Benefit Managers (PBM) use to over-inflate the cost of prescription medications at the point-of-sale transaction. Essentially, a PBM clawback forces some pharmacies to charge customers more than the pharmacy's cash price. The PBM then "claws back" from the pharmacy the money the patient was overcharged.
IPC Illinois Members: HB 3479 UPDATE - Action Needed TODAY!
May 29, 2018
Contact State Leadership Committee TODAY Urge them to Support HB 3479. Time Critical Action Needed for Amendments to MCO Prescription Reform Bill. IPC, the Illinois Pharmacists Association and other industry stakeholders' efforts to end Illinois Medicaid's MCO's prescription below costs payments, with a legislative fix by IL State Rep. Sara Feigenholtz (D-Chicago) (HB 3479) continues today. This strong PBM regulation amendment is up in the powerful Senate Executive Committee today at 3:45 p.m. in the State Capitol.
Legislative Action Center
State Legislative Tracking